Objective: Inadequate vitamin D status is related to increased adiposity, risk of falls, and muscle weakness, particularly in older people. We hypothesized that serum 25-hydroxyvitamin D [25(OH)D] is related to physical fitness indices (androidal fat, whole body lean mass, balance, strength) in healthy postmenopausal women.
V itamin D deficiency can cause life-long sequelae, ranging from skeletal deformation and growth retardation in children to osteopenia, osteoporosis, and osteomalacia in adults. 1 Based on a large study that included 18 countries worldwide, 64% of postmenopausal women with osteoporosis had vitamin D inadequacy. 2 Vitamin D deficiency can be exacerbated during the winter months because of lack of exposure to UV-B rays, 3, 4 although location does not always dictate vitamin D status. Vitamin D status is based on serum 25-hydroxyvitamin D [25(OH)D; 25(OH)D 2 plus 25(OH)D 3 ] concentration (in nanomoles per liter) [in nanograms per milliliter]: deficient, e50 [e20]; insufficient, 51-74 [21] [22] [23] [24] [25] [26] [27] [28] [29] ; sufficient, 75-100 [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ; or intoxication, 9374 [150]. 1, 5, 6 Higher serum 25(OH)D is associated with better physical performance. 7, 8 Vitamin D deficiency among older men and women (age, 65+ y) was associated with slower performance for chair stands and tandem stands (serum G25 nmol/L [10 ng/mL]) and slower walking time (serum G49.2 nmol/L [20 ng/mL]). Furthermore, physical performance improved with increasing 25(OH)D, but performance leveled off at greater than 50 nmol/L (20 ng/mL). 8 The health benefits of physical activity include improved muscle fitness and reduction in falls, but these benefits may also be related to 25(OH)D concentration. 9 Whereas vitamin D deficiency causes muscle weakness, 10 greater serum 25(OH)D concentration has been associated with improved muscle function, 9, 11, 12 improved balance, 9, 12 reduced risk of falling, 7, 9, 12 and decreased fracture rate. 13 The Third National Health and Nutrition Examination Survey III data indicated that among 4,100 older people (60+ y of age), those with lower status (G40 nmol/L) had slower performances, whereas those with better status (940 nmol/L) had faster performances. 7 Although performance speed was faster in the range of 40 to 94 nmol/L compared with lower status (G40 nmol/L), the performance speed slope was much less dramatic in this range. These analyses were adjusted for demographics, comorbidities, calcium intake, and physical activity. Serum 25(OH)D (ranging from 24.5 to 58.9 nmol/L) has been shown to be related to functional performance (walking, rising from a chair, ascent and decent of 13 stairs), choice reaction time, 14 and balance (bipedal postural sway and balance on one leg) but not to quadriceps strength. 15 A metaanalysis 9 stated that an explanation for the improvement in muscle function may be that 1,25(OH) 2 vitamin D (1,25(OH) 2 D derived from 25(OH)D) binds to a highly specific nuclear receptor in muscle tissue, which leads to de novo protein synthesis and hence muscle cell growth.
Moderate-to-high cardiorespiratory exercise has been associated in both men and women with reduced total body and abdominal fat mass (particularly visceral fat), independent of change in body mass index (BMI). 16 25 (OH)D concentration has been shown to be inversely related to weight, BMI, fat mass, and waist-to-hip ratio. 17/20 The purpose of this cross-sectional analysis was to examine the relationship between serum 25(OH)D, taking into account weight, age or years since menopause, serum high-sensitivity C-reactive protein concentration, white blood cell (WBC) count, energy expenditure (in kilojoules per week), and various dietary intake factors and indicators of physical fitness (androidal fat mass, lean mass, strength, and balance) in healthy postmenopausal women who were selected as part of a longitudinal study on bone mineral density (BMD).
METHODS

Study design
Healthy postmenopausal women aged 45.8 to 65.0 years were enrolled as part of a randomized, double-blind, placebocontrolled multicenter (Iowa State University [ISU], Ames, IA, and University of California at Davis [UCD], Davis, CA), National Institutes of HealthYfunded clinical trial that began in 2003. The parent study (Soy Isoflavones for Reducing Bone Loss [SIRBL]) was designed to examine the effect of two doses of isoflavones extracted from soybeans on bone loss for 3 years in at-risk postmenopausal women who upon entry were nonosteoporotic, without diseases or conditions, and not taking hormones or medications. This ancillary project focused on the relationship between serum 25(OH)D concentration and overall physical fitness at baseline for 242 women. We excluded 13 women at UCD from this analysis because they did not meet the entry criteria (11 had thickened endometrium, 1 had breast cancer, 1 could not provide a blood sample).
Participant screening, selection, and characteristics
For the parent SIRBL project, we recruited participants throughout the state of Iowa and the Sacramento region in California primarily through direct mailing lists, stories in local newspapers, local/regional radio advertisements, and other recruiting avenues. Women who responded (N = 5,255) to outreach materials were initially screened via a telephone questionnaire to identify healthy women who underwent natural menopause (cessation of menses 9 mo to 10 y), were not experiencing excessive vasomotor symptoms, were 65 years or younger, were nonsmokers, and had a BMI (in kilograms per meter squared) ranging from 18.5 through 29.9 (inclusive) to exclude women at the extremes of adiposity. We excluded vegans and high alcohol consumers (97 servings/wk) because alcohol interferes with isoflavone metabolism. The parent SIRBL project established the inclusion/exclusion criteria; thus, we excluded women diagnosed with chronic disease and those who had a first-degree relative with breast cancer. We also excluded women based on the following criteria: long-term use of medications (cholesterol-lowering or antihypertensive medications); use of oral hormone or estrogen therapy, selective estrogen-receptor modulators, or other hormones within the last 12 months; use of estrogen or progestogen creams or calcitonin within the last 6 months; use of antibiotics within the last 3 months; and/or any previous use of bisphosphonates.
Women who met the initial criteria via telephone (n = 677) attended a prebaseline appointment to determine eligibility for additional entry criteria. We measured height and weight to confirm BMI status and used a Delphi W QDR dualenergy x-ray absorptiometry (DXA) bone densitometer (Hologic, Bedford, MA) to assess BMD to establish eligibility. The SIRBL project focused on prevention rather than treatment of disease; thus, we excluded women based on lumbar spine and/or proximal femur BMD (using 91.5 SD below the young adult mean as cutoff), with evidence of previous or existing spinal fractures, or with a high BMD (91.0 SD above the mean). Once a woman qualified based on her BMD, our phlebotomist drew blood for a chemistry profile. We excluded women if their fasted blood values indicated diabetes mellitus (fasting blood glucose Q126 mg/dL); abnormal renal (elevated creatinine), liver (elevated enzymes), and/or thyroid function; or elevated lipid profile (low-density lipoprotein cholesterol 9160 mg/dL; triacylglycerol 9200 mg/dL). For this ancillary project, we included 242 women who met our entry criteria ( Fig. 1) for the crosssectional analysis.
The respective institutional review boards at ISU (ID no. 02-199) and at UCD (ID no. 200210884-2) approved our study protocol, consent form, and participant-related materials. Approvals for the DXA procedures were obtained from each institution's institutional review board and State Department of Public Health in Iowa and California. We obtained informed consent from all women at the start of prebaseline screening.
Data collection Questionnaires
At the prebaseline visit, trained interviewers administered three questionnaires to ensure the health status of participants: health and medical history, 21 reproductive history, 22 and nutrition history. 21 Participants were asked to cease taking herbal therapies and/or dietary supplements before baseline testing. At baseline, we assessed dietary intake using a semiquantitative food frequency questionnaire from the Block Dietary Data Systems (Berkeley, CA). We assessed physical activity using the Paffenbarger physical activity recall 23 to obtain information from the previous year's activity, including walking, climbing stairs, sport and recreational activity, and time spent engaged in activities ranging from light to heavy activity. Each reported recreational or work-related activity was summed using metabolic equivalents of 4, 6, or 8 for activities classified as light, moderate, or heavy, respectively. The summation of activities provided an estimate of weekly energy expenditure for these physical activities.
Body size and composition measurements
A trained anthropometrist measured standing and sitting heights (model S100; Ayrton Corp., Prior Lake, MN) and weight (ABCO Health-o-meter, Bridgeview, IL). Body composition measurements were obtained using matching DXA instruments (Delphi W) at each site and daily calibration to ensure that the instruments provided comparable results. One certified DXA operator at ISU and one at UCD performed all DXA scans, with cross-training between sites to ensure comparable quality control. We standardized participant placement for the scans and adhered to the manufacturer's recommendations. One operator assessed overall adiposity from the whole body DXA scans. To assess central adiposity, one evaluator sectioned each whole body DXA scan into waist, hip, and thigh regions based on bone landmarks, 24, 25 and these regions were analyzed using a special software (Discovery Version 12.3:7). The waist region included the first lumbar through the fourth lumbar vertebrae. The hip region began below the fourth lumbar vertebrae and extended to the tip of the greater trochanter of the femur. Lastly, the thigh region extended superiorly from the greater trochanter to the approximate midpoint between the edge of the thigh region and lateral condyle of the femur. The lateral edge of each region was extended distally to encompass all tissue. This analysis provided an estimate of the fat and lean mass within each of these three regions. The androidal-to-gynoidal fat mass ratio was calculated for each participant: waist + hip fat mass/thigh fat mass.
Laboratory measurements
Phlebotomists collected fasted (9 h) blood samples between 0700 and 0800 h. Serum samples were allowed to clot for 30 minutes before centrifugation. We separated serum and plasma from whole blood by centrifuging for 15 minutes (4-C) at 1,300 Â g and stored aliquots at j80-C until analyses. Certified clinical laboratories (LabCorp, Kansas City, KS, for ISU, and UCD Medical Center, Sacramento, CA, for UCD) analyzed our blood samples, including a complete blood count with differential, general chemistry panel, and thyroid screen. Serum 25(OH)D concentration was determined for each individual in duplicate with radioimmunoassay kits (25(OH)D 125 I radioimmunoassay kit; DiaSorin, Stillwater, MN) using a Cobra II series auto-gamma counting system (PerkinElmer Life and Analytical Sciences, Meriden, CT). We report the total circulating serum 25(OH)D [25(OH)D 2 plus 25(OH)D 3 ] because clinical decisions are based on these total values. 26 According to Hollis, 26 the only assays that quantitatively detect total circulating 25(OH)D are the high-performance liquid chromatography and liquid chromatographyYmass spectrometry methods and the DiaSorin assay. During specimen collection and preparation, we were careful and only exposed serum and plasma samples minimally to light. According to the manufacturer's instructions, we used single-serum aliquots for extraction; duplicate samples were then taken from the supernatant for subsequent analysis. We used quality control samples included in the DiaSorin kit, with low to normal reference values ranging from 26.0 to 55.9 nmol/L and normal to high reference values ranging from 95.4 to 203.2 nmol/L. We used these ranges as the basis for accepting sample data veracity for each batch/run, which included six standards in duplicate. We collected sufficient in-house serum as quality control (frozen at j80-C) to run with each kit for calculating the interassay coefficient of variation (CV). To determine the intra-assay CV, we used a duplicate serum sample CV based on all data points. The intra-assay and interassay CVs, respectively, were 2.71% and 2.69.%
Statistical analyses
Statistical analyses were performed using SAS (version 9.1; SAS Institute, Cary, NC), with results considered statistically significant at P e 0.05. Descriptive statistics included means T SD for all data, because most were normally distributed data, with range provided for each variable. Classes of variables in modeling the outcomes of interest included independent variables that were biologically plausible and/or significantly related using Pearson's correlation analysis. We used stepwise regression analyses to assess the combined contribution of independent variables to androidal fat mass, whole body lean mass, single-leg balance, and strength (hand, torso, and leg). Classes of variables in modeling each of these six outcomes included weight, age or years since menopause, circulating 25(OH)D, serum C-reactive protein concentration, WBC count, energy expenditure (in kilojoules per week), and various dietary intake factors (calcium intake [total, supplemental, or dairy], energy, protein, saturated fat, and/or vegetable servings). Each model included site as an obligatory variable to account for potential study site differences, with the ISU site folded into the model intercept and the UCD site indicated in the table. In modeling each outcome, we removed variables that exhibited multicollinearity as indicated by the variance inflation factor. The variance inflation factor measures the impact of collinearity among the independent variables in a regression model and the degree to which multicollinearity degrades the precision estimate. A value exceeding 10 is of concern, but in weaker regression models, a value exceeding 2.5 may be cause for concern. 27 RESULTS
Participant characteristics
These analyses included 242 healthy postmenopausal women, with baseline characteristics presented in Table 1 . Women ranged from 45.8 to 65.1 years of age and were from 0.8 to 10.0 years since menopause. We enrolled three African American (1%), one Native Hawaiian (G1%), one Native American (G1%), three Asians (1%), seven women of more than one race (3%), two of unknown race (G1%), and two who chose not to report race (G1%); the remaining women were white (92%). BMI values ranged from 17.8 to 32.7 kg/m 2 ; UCD enrolled women beyond our inclusion criteria (two women with a BMI lower than 18.5 kg/m 2 and seven women with higher than 29.9 kg/m 2 ). Overall and regional body composition as assessed by DXA (Table 1) indicated wide variability in both overall and regional body fat measures among these women. Approximately half of the women had a BMI less than 25.0 kg/m 2 . Values for circulating analytes are presented in Table 1 , demonstrating that mean values were within the range reported in the literature. The mean values for dietary and supplement (calcium and vitamin D) intake ( Table 2 ) illustrated wide variability in intake.
Serum 25(OH)D indicated that 19.4% of participants were deficient (G50 nmol/L), 44.2% were insufficient (50-74.9 nmol/L), and 36.4% were sufficient (975 nmol/L). A total of 130 women (70 at ISU and 60 at UCD) who had taken vitamin D supplements before baseline had a mean 25(OH)D concentration of 72.9 nmol/L, whereas those who had not taken supplements had a mean value of 65.9 nmol/L. Women from the UCD site (71.1 T 22.7 nmol/L) had a 6% higher mean (TSD) serum 25(OH)D concentration than those from the ISU site (67.7 T 21.1 nmol/L), but this difference was not significant (P = 0.18). Serum 25(OH)D ranged from 65.0 nmol/L in winter to 79.6 nmol/L in summer, with Variables left in the model were significant at P e0.10 level. c VIF measures the impact of collinearity among the independent variables in a regression equation and the degree to which multicollinearity degrades the precision estimate. d Number of participants = 242 for most variables, except n = 241 for energy expenditure, n = 240 for balance, n = 239 for torso and leg strength, and n = 237 for handgrip strength and WBC count. e Each model included site as an obligatory variable to account for potential study site differences, with the ISU site folded into the model intercept and the UCD site indicated separately. f Balance was log transformed because it was not normally distributed. 
Regression analyses
We performed regression analyses to examine the independent factors contributing to the variability in androidal fat mass, whole body lean mass, balance, and strength (hand, torso, and leg) as our primary outcomes (Table 3) . No notable multicollinearities emerged among the independent variables, as indicated by the low (G2) variance inflation factors in all regression models. Residual analyses indicated that the model assumptions of normality of error terms and homogeneity of error variance were satisfied for the final regression models. Geographic site was significant for torso strength (P e 0.0001) and leg strength (P = 0.0007) but not for androidal fat mass, whole body lean mass, handgrip strength, and balance. Nevertheless, we retained site as obligatory in each model to account for the potential influence of site. We explored the relationship between serum 25(OH)D and each outcome variable graphically, with these scatterplots showing a continuously linear relationship between 25(OH)D and each outcome variable. Based on our data, we found no firm indication of a threshold effect of 25(OH)D on the outcomes of interest. After stepwise variable selection was completed, multiple regression analyses revealed that weight (53%), WBC count (2.0%), supplemental calcium (1.7%), years since menopause (1.1%), 25(OH)D (1.0%), and vegetable servings per day (0.6%) accounted for 71% of the variability in androidal fat mass (F = 78.8, P e 0.0001). Likewise, weight (63%), WBC count (1.4%), and 25(OH)D (1.0%) accounted for 64% of the variability in whole body lean mass (F = 100.9, P e 0.0001). Age (3.8%), 25(OH)D (2.0%), and WBC count (1.8%) accounted for 12% of the variability in balance (F = 6.2, P e 0.0001). Multiple regression analyses revealed that weight (9.3%), 25(OH)D (2.4%), WBC count (2.1%), and age (1.6%) accounted for 14% of the variability in handgrip strength (F = 7.2, P e 0.0001), whereas site (15.0%), weight (4.6%), and energy expenditure (1.2%) accounted for 22% of the variability in torso strength (F = 22.0, P e 0.0001), and weight (5.0%), site (4.5%), WBC count (2.0%), energy expenditure (1.8%), and age (1.3%) accounted for 14% of the variability in leg strength (F = 7.4, P e 0.0001).
DISCUSSION
Only 36.4% of our participants were vitamin D sufficient (975 nmol/L), whereas 63.6% were either vitamin D insufficient (44.2%) or deficient (19.4%). Vitamin D is a hormone synthesized from cutaneous 7-dehydrocholesterol in response to UV-B exposure, 28 but vitamin D can also be obtained from dietary sources or supplements. The women in this study were asked to refrain from supplement use before baseline, but we did not control their dietary sources or cutaneous UV-B exposure. Although assessment of vitamin D using a questionnaire provides a very rough estimate at best, dietary intake of vitamin D was 162 and 114 IU/day for the ISU and UCD women, respectively. Although increased skin pigmentation, use of sunscreen, clothing, aging, and latitude decrease the cutaneous synthesis of previtamin D 3, 28 we did not take these factors into account. Instead, we assessed circulating 25(OH)D concentration to account for vitamin D status among individuals and between sites. Between sites, the distributions had a similar shape and range (ISU and UCD: 26.0-146.6 and 21.6-157.6), illustrating that such typically low dietary intake of vitamin D does not contribute appreciably to serum 25(OH)D.
Serum 25(OH)D was the common contributor to physical fitness indices (androidal fat mass, whole body lean mass, balance, and handgrip strength) in healthy postmenopausal women in our cross-sectional study. Indeed, women with insufficient and deficient 25(OH)D, respectively, had 8.5% and 12.3% higher mean fat mass than that of those with sufficient status, suggesting that vitamin D status may contribute to adiposity, as previously indicated in a randomized controlled trial of 90 young women. 29 In a study with healthy older adults that provided supplemental calcium and vitamin D 3 , the change in plasma 25(OH)D was negatively associated with waist circumference and central but not peripheral fat. 30 Similarly, in healthy women 20 to 80 years of age, serum 25(OH)D was negatively related to total body fat percentage after adjusting for race, season, age, and dietary vitamin D. 20 Accordingly, we noted an inverse relationship between serum 25(OH)D and androidal fat mass, although this does not demonstrate causality. The literature is not in complete agreement as to why obese individuals have compromised vitamin D status, although serum 25(OH)D is typically inversely related to parathyroid hormone concentration. 31 One prevailing thought is that 25(OH)D is sequestered in fat cells, 32 thereby lowering circulating 25(OH)D. This does not preclude other potential mechanisms, such as an enhanced metabolic clearance of 25(OH)D by hepatocytes in obese individuals. 33 We also noted a positive link between years since menopause and androidal fat, similar to a study 34 in 29 healthy postmenopausal women who had significantly (P = 0.04) higher visceral adipose tissue compared with premenopausal women. We noted a statistically significant inverse relationship between supplemental but not dairy-derived calcium with androidal fat mass, perhaps because approximately one third of the women did not take calcium supplements at baseline. In contrast, data from clinical trials 35/37 have indicated a twofold greater effect of dairy versus supplemental sources of calcium in attenuating adiposity. Interestingly, vegetable servings per day also contributed to androidal fat mass, somewhat similar to a study 38 reporting that dietary fiber and fruit servings per day were inversely related to percentage body fat in 52 overweight/obese versus 52 normal-weight adults.
As expected, 25(OH)D was directly related to lean body mass in our study, which has not been fully explored by researchers, perhaps because the adiposity story has overshadowed the relationship between vitamin D status and lean mass. A study in the elderly 39 demonstrated that vitamin D osteopathy was largely mediated through lean mass in men, with serum 25(OH)D being related (r = 0.24, P = 0.002) to lean body mass in men but not in women. Furthermore, Wortsman et al 32 noted an inverse relationship between serum 25(OH)D and BMI, a combination of adiposity and lean body mass, in a relatively small sample (n = 38) of medical school personnel (age and sex unstated). In a group of postpubescent adolescent Chinese girls (N = 323), 39 serum 25(OH)D related positively not only to BMI but also to whole body lean mass, yet not to percentage body fat (based on DXA measurements). A study in young females (16-22 y) 40 demonstrated an inverse relationship between serum 25(OH)D versus weight (r = j0.28, P = 0.007) or versus BMI (r = j0.35, P = 0.001), but they did not report lean body mass. Depending on the overall level of adiposity, BMI is more reflective of lean mass at the lower end of the adiposity spectrum. The significance of the relationship between vitamin D status and body composition needs further investigation, but it is important to note that we observed this link in Bhealthy[ postmenopausal women.
The women in our study with insufficient and deficient vitamin D status had 5.7% and 10.6%, respectively, poorer mean balance than that of those with sufficient status, suggesting that vitamin D status may contribute to better balance as supported by previous studies. 41, 42 A cross-sectional study 8 in men and women 65 years or older showed that decreased serum 25(OH)D (e50 nmol/L [e20 ng/mL]) was associated with decreased physical performance. Furthermore, during the 3-year longitudinal portion of this study, 8 researchers showed that continued insufficient vitamin D status was associated with higher odds of decline in physical performance when compared with controls (Q75 nmol/L [Q30 ng/mL]). A cross-sectional study 7 with 4,100 participants from the third National Health and Nutrition Examination Survey assessed lower-extremity function in a subset of ambulatory men and women aged 60 to 90+ years. The data were adjusted for other factors that predicted lower-extremity function: age, sex, ethnicity, BMI, comorbid conditions (such as arthritis), level of activity, use of walking device, and poverty-income ratio. The researchers observed significant negative associations (P e 0.0001) between serum 25(OH)D and walking ability and the sit-to-stand test; as serum 25(OH)D increased, it took less time to perform these tasks. Most of the improvement in performance speed was evidenced as serum 25(OH)D increased from 22.5 to È40 nmol/L, whereas smaller improvements were made in the range from 40 to 94 nmol/L. 7 Serum 25(OH)D was identified as a significant independent variable for functional performance-aggregate time (P G 0.05), muscle strength adjusted for age (P = 0.02), postural stability (sway and balance) (P = 0.03), and psychomotor function-choice reaction time (P G 0.05) in a group of older participants prone to falling. 15 Similarly, low 25(OH)D (G25 nmol/L) was independently associated with a higher risk of recurrent falling, 43 mediated by physical performance (impairment of gait, pos-tural balance, and muscle strength) among men and women aged 65 to 75 years of age, suggesting that vitamin D status affects muscle function. Certainly, age is an important contributor to balance, as we observed in our study. This was clearly illustrated in women 40 to 60 years of age who participated in a 12-week balance-strategy training program 44 that either preserved or reversed the decline in balance associated with age, as well as improved muscle strength. Interestingly, in our study, body weight was inversely related to balance but was positively associated with each of the other indicators of fitness.
The women in our study with insufficient and deficient vitamin D status had 3.1% and 7.3%, respectively, lower mean handgrip strength than that of those with sufficient status, with handgrip strength similar between geographic sites. Correspondingly, vitamin D insufficiency and deficiency have been linked to increased risk of muscle weakness. 10 However, we also found that women with insufficient and deficient vitamin D status had 9.5% and 2.6%, respectively, higher mean torso strength than that of those with sufficient status. Overall body strength, reflected by torso and leg strength, is determined by many factors (ie, strength training, genetic predisposition, activities of daily living, etc), most of which we did not include in our analyses, with the exception of body weight and energy expenditure assessed by the Paffenbarger Questionnaire. Strength training increased muscle mass and strength, balance, and overall levels of physical activity in postmenopausal women, 41 but our study did not involve exercise intervention. It may be that we did not capture additional influences on overall body strength but that handgrip strength was more strongly impacted by 25(OH)D. Another explanation for these results might have been that torso and leg strength differed according to site but had nothing to do with vitamin D status. Indeed, site contributed significantly to torso and leg strength (P e 0.0001, P = 0.0007); ISU participants had 24% greater mean torso strength and 16% greater mean leg strength than that of those at UCD. Perhaps the greater strength in ISU women was related to their involvement in farm chores and lifting heavy objects (data not shown) or that the age range was narrower for ISU women and age was inversely related to strength.
In our cross-sectional study, WBC count was a significant contributor to most of the fitness outcomes: positively associated with androidal fat mass but negatively associated with whole body lean mass, balance, and strength measures (handgrip and leg). These results suggested that low WBC count may be a good indicator of overall health as indicated by others 45 ; it is important to note that none of the women in our study had elevated WBC count (reference range, 4.5-10.5 Â 10 9 /L). 46 Elevated WBC count is also an indicator of inflammation and has been associated with obesity and morbid obesity in women, 47 as well as in both men and women. 48 A 2-year study 49 in 477 men and women who had undergone lap-band surgery reported that WBC count declined by 14% (P G 0.001) as BMI decreased by 24% (P G 0.001), providing further evidence for the link between weight and WBC count.
The primary limitation of this study is that it was crosssectional, and thus, we cannot imply cause and effect. In addition, we cannot apply these results to groups other than postmenopausal women. However, the value of this study is that it illustrates the importance of vitamin D status in a group of healthy postmenopausal women who were not chosen based on their vitamin D status, yet only approximately one third of these women had sufficient vitamin D status at baseline.
CONCLUSIONS
This study provides some basis for suggesting that many healthy women do not have adequate vitamin D status, which is important for functional indices of health, providing evidence to test serum 25(OH)D clinically.
